Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular hypertrophy and hypertension: causes and consequences

P I Korner1

  • 1Baker Medical Research Institute, Melbourne, Victoria, Australia.

Blood Pressure. Supplement
|January 1, 1995
PubMed
Summary

Chronic hypertension involves increased vascular resistance and left ventricular (LV) hypertrophy, impacting blood pressure and organ health. Targeting hypertrophy regression is crucial for preventing organ damage in hypertensive patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The phenotypic patterns of essential hypertension are the key to identifying "high blood pressure" genes.

Physiological research·2011
Same author

Structure and the resistance amplifier in hypertension: reply to the dissenters.

Journal of hypertension·2000
Same author

Assessment of prevalence of left ventricular hypertrophy in hypertension.

Journal of hypertension·1998
Same author

Vascular remodeling.

Hypertension (Dallas, Tex. : 1979)·1997
Same author

Circulatory control and the supercontrollers.

Journal of hypertension·1995
Same author

Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats.

Hypertension (Dallas, Tex. : 1979)·1995

Area of Science:

  • Cardiovascular Physiology
  • Hypertension Research
  • Vascular Biology

Background:

  • Chronic hypertension is characterized by elevated vascular resistance and left ventricular (LV) hypertrophy, particularly in animal models.
  • These changes contribute to enhanced hemodynamic performance, maintaining elevated blood pressure and microcirculatory exchange.
  • Vascular remodeling, including luminal narrowing without increased medial mass, can result from non-uniform wall stress distribution.

Purpose of the Study:

  • To explore the mechanisms underlying elevated blood pressure and structural changes in chronic hypertension.
  • To investigate the roles of angiotensin II, sympathetic nervous system, and angiotensin-converting enzyme (ACE) in hypertension development.
  • To assess the potential benefits of targeting cardiovascular hypertrophy regression in human hypertension therapy.

Related Experiment Videos

Main Methods:

  • Analysis of hemodynamic changes and vascular remodeling in hypertensive models (e.g., Goldblatt hypertension, Spontaneously Hypertensive Rats - SHR).
  • Investigation of the effects of interventions like neonatal sympathectomy, prazosin treatment, and ACE inhibitors.
  • Examination of the impact of antihypertensive drugs on cardiovascular hypertrophy regression in human hypertension.

Main Results:

  • Goldblatt hypertension involves renal artery stenosis resistance, angiotensin II (AngII) effects, and later, cardiovascular amplifier roles.
  • Sympathetic nervous system activity is critical for BP elevation and structural changes in SHR; sympathectomy prevents these.
  • ACE plays a similar role in cardiovascular development in SHR and WKY rats; ACE inhibitors attenuate hypertension long-term in SHR.

Conclusions:

  • Therapeutic strategies aimed at regressing cardiovascular hypertrophy are valuable in managing human hypertension.
  • Hypertrophy regression can mitigate non-uniform capillary blood flow distribution, reducing the risk of rarefaction and organ damage.
  • Understanding the complex interplay of vascular resistance, hypertrophy, and neurohormonal factors is key to effective hypertension management.